Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 – Regional Analysis and Forecasts by Type, Disease Indication, Technology, and End User The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 2,570.37 Mn in 2027 from US$ 878.28 in 2018. The market is estimated to grow with a CAGR of 12.8% from...
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage. The report provides...
The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 1,679.956 Mn in 2027 from US$ 630.914 in 2018. The market is estimated to grow with a CAGR of 11.6% from 2019-2027. The key factors responsible for the growth of the market in Asia Pacific are rising burden of genetic diseases among infants, increasing...
The North America hereditary cancer testing market is expected to reach US$ 3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018. This market is projected to grow at a growth rate of 11.6% from 2019-2027. The growth of the hereditary cancer testing market is primarily attributed to increasing as increasing prevalence of hereditary cancer and...
The Global Genetic Testing Market size is expected to reach $16.9 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period. Genetic testing is the study of the cells and tissues contained in the gene. In the field of biology and medicine, this study is further implemented to get a better understanding of genetic...
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Liver Cancer Diagnostic Tests currently in pipeline stage. The report provides...
Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Cervical Cancer Diagnostic Tests currently in pipeline stage. The report...
Executive Summary According to the report, the Liquid Biopsy was valued at USD 899.55 million for the year 2018. Over the recent years, Liquid Biopsy has been witnessing considerable growth on the back of growing focus on immunotherapy to cure cancer and shifting trend towards precision medicine along with high per capita...
The global colorectal cancer market is expected to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018. The market is anticipated to grow with a CAGR of 4.0% from 2019-2027. Driving factors of the colorectal cancer are increasing prevalence of colorectal cancer, new product launches and benefits offered by generic drugs. Moreover,...
The Global Oncology Partnering 2014-2019: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Oncology partnering deals Financial deal terms for headline, upfront and royalty...